Kania, K. (2023) “FDA Approves Omaveloxolone based on Successful Moxie Trial Results for Friedreich’s Ataxia - Review”, Journal of Education, Health and Sport, 40(1), pp. 111–126. doi: 10.12775/JEHS.2023.40.01.010.